Predicine
PrivateLast Round
Series B
Jul 29, 2020
Total Funding Raised
$37.8M
Momentum
Quiet
No recent growth signals
Company Overview
Predicine is a biotechnology company that develops a cell-free DNA- and cell-free RNA-based liquid biopsy technology for cancer diagnostics and monitoring.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Clinical Trials, Biotechnology, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Predicine Comps
Public and private peers based on sector, stage, and business model.
Predicine Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 29, 2020 | ||||
| Series A | Apr 16, 2018 | ||||
| Pre Seed | May 15, 2017 |
Predicine Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Shenzhen Sangel Venture Capital | Series B, Series A |
| Highlight Capital | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 2, 2025
Monthly visitors grew 210% MoM, reaching 1.5K.
- Jul 29, 2020
$14.3M round with Highlight Capital and Shenzhen Sangel Venture Capital.
Predicine Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Predicine's valuation, stock price, and market status.
